Clinical Trials Browser

INDUSTRY × Urinary Bladder Neoplasms × fludarabine × Clear all

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell

NCT04319757 2024-12-05

ACE1702 in Subjects With Advanced or Metastatic HER2-expressing Solid Tumors

BreastGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Clinical Trials

DUET-UC-NK

ACE1702 in Subjects With Advanced or Metastatic HER2-expressing Solid Tumors